NCT01124747View on ClinicalTrials.gov

A Study to Assess the Systemic Disposition of ASP1585 After Administration of 14C-labeled Drug

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
HealthyPharmacokinetics of ASP1585
Interventions
DRUG

ASP1585

Oral

DRUG

14C-Labeled ASP1585

Oral

Trial Locations (1)

53704

Madison

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY